KATHERINE DOWELL: Open Payments
NPI 1497501480 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 61 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $560 · 2025 $1,890
Food & beverage: $1,611Education: $279
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $638 |
| Galderma Laboratories, L.P. | 4 | $167 |
| Organon LLC | 4 | $164 |
| Novartis Pharmaceuticals Corporation | 2 | $154 |
| Amgen Inc. | 3 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $117 |
| UCB, Inc. | 5 | $115 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Smith+Nephew, Inc. | 1 | $40 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, VTAMA, OTEZLA, Rhapsido, Bimzelx, GRAFIX PL.
Industry payments across MO — which companies pay providers there.
